To measure the amount of copper in the blood, urine, or liver tissue; to help diagnose and monitor Wilson disease; sometimes to identify copper deficiency or excess
Copper
Copper
Also Known As
Cu
Urine Copper
Blood Copper
Free Copper
Hepatic Copper
Formal Name
Copper, 24-hour urine, blood, and liver (hepatic) tissue
This article was last reviewed
on
This article waslast modified
on December 7, 2017.
At a Glance
Why Get Tested?
When To Get Tested?
When you have jaundice, fatigue, abdominal pain, behavioral changes, tremors, or other symptoms that a health practitioner thinks may be due to Wilson disease or, rarely, to copper deficiency or excess; at intervals when you are being treated for a copper-related condition
Sample Required?
A blood sample drawn from a vein in your arm and/or a 24-hour urine sample; sometimes a liver biopsy sample
Test Preparation Needed?
None
Accordion Title
Common Questions
-
How is it used?
Copper testing is primarily used to help diagnose Wilson disease, a rare inherited disorder that can lead to excess storage of copper in the liver, brain, and other organs. Less commonly, a copper test may be used to detect copper excess due to another condition, to detect a copper deficiency, or to monitor treatment for one of these conditions.
Copper is an essential mineral but in excess, it can be toxic. In the blood, most of it is incorporated into the enzyme ceruloplasmin and only a small amount is in a "free" or unbound state. (See the "What is being tested?" section for more on this.)
Typically, a total blood copper test is ordered along with a ceruloplasmin level. If the results from these tests are abnormal or unclear, then they may be followed by a 24-hour urine copper test to measure copper elimination and/or a copper test performed on a liver biopsy to evaluate copper storage in the liver.
Sometimes a free (unbound) blood copper test is also ordered. If Wilson disease is suspected, genetic testing may be performed to detect mutations in the ATP7B gene. However, these tests have limited availability and are usually performed in special reference or research laboratories.
Rarely, a copper test may be used to help diagnose Menkes kinky hair syndrome, a rare inherited disorder of copper transport dysfunction. (See Common Questions #4.)
-
When is it ordered?
One or more copper tests are ordered along with ceruloplasmin when someone has signs and symptoms that a health practitioner suspects may be due to Wilson disease, excess copper storage, or copper poisoning. These signs and symptoms may include:
- Anemia
- Nausea, abdominal pain
- Jaundice
- Fatigue
- Behavioral changes
- Tremors
- Difficulty walking and/or swallowing
- Dystonia
Testing may be ordered when a person has signs and symptoms that may be due to a copper deficiency, such as:
- Abnormally low numbers of neutrophils, a type of white blood cell (neutropenia)
- Osteoporosis
- Anemia
- Less commonly, neurologic symptoms and delayed growth in children
One or more of the copper tests may be ordered periodically when monitoring is recommended.
A hepatic (liver) copper test may be ordered to further investigate copper storage when copper and ceruloplasmin results are abnormal or equivocal.
-
What does the test result mean?
Copper test results must be evaluated in context and are usually compared to ceruloplasmin levels. Abnormal copper results are not diagnostic of a specific condition; they indicate the need for further investigation. Interpretation can be complicated by the fact that ceruloplasmin is an acute phase reactant – it may be elevated whenever inflammation or severe infections are present. Both ceruloplasmin and copper are also increased during pregnancy and with estrogen and oral contraceptive use.
Test results may include:
Test Wilson Disease Copper Toxicity Menkes Disease (Kinky Hair Syndrome) Copper Deficiency Copper, blood Low but may be normal High Low Low Copper, serum free High High Low Low Ceruloplasmin Low but may be normal High Low Low Copper, urine Very high High Low Low Copper, liver/hepatic* Positive but, depending on the site sampled, may be negative High or normal Low Low *Excess copper in the liver is often unevenly distributed and may not be detected in a sample.
- Low blood copper concentrations along with increased urine copper levels, low ceruloplasmin levels, and increased hepatic copper are typically seen with Wilson disease.
- Increased blood and urine copper concentrations and normal or increased ceruloplasmin levels may indicate exposure to excess copper or may be associated with conditions that decrease copper excretion, such as chronic liver disease, or that release copper from tissues, such as acute hepatitis. Increased hepatic copper may be present with chronic conditions.
- Decreased blood and urine copper concentrations and decreased ceruloplasmin may indicate a copper deficiency.
- A normal hepatic copper test may indicate that copper metabolism is functioning properly or that the distribution of copper in the liver is uneven and the sample is not representative of the person's condition.
If a person is being treated for Wilson disease or copper toxicity with drugs that bind copper (chelators), then that person's 24-hour urine copper levels may be high until body copper stores decrease. Eventually, blood copper and 24-hour urine copper concentrations should normalize.
If someone is being treated for a condition related to copper deficiency and the person's ceruloplasmin and total copper concentrations begin to rise, then the condition is likely responding to the treatment.
-
Is there anything else I should know?
Medications such as carbamazepine and phenobarbital can increase blood copper levels. They may also be elevated with rheumatoid arthritis and with some cancers and decreased with a variety of conditions associated with malabsorption, such as cystic fibrosis.
Total serum copper concentrations are normally low at birth, rise over the next few years, peak, and then decline slightly to a relatively stable level.
Care must be taken, especially with a 24-hour urine sample, not to contaminate the sample with an external source of copper. Talk to the health practitioner and/or the laboratory that will perform the test about necessary precautions. If a urine or blood copper test result is higher than expected, the health practitioner may have the test repeated with a new sample to confirm the findings.
-
Should everyone's copper metabolism be evaluated?General screening for copper concentrations is not recommended or necessary. Many people with conditions not associated with copper, such as people with infections or inflammation, may have temporarily increased concentrations.
-
Can I choose either a blood (total or free) or urine copper test?
These tests provide complementary information and your healthcare provider will determine which tests are necessary to evaluate your condition.
-
Should I be taking copper supplements or trying to get more copper in my diet?
In most cases, a regular diet satisfies the body's requirements for copper. Talk to your healthcare provider before taking any supplements or changing your diet.
-
What is Menkes kinky hair syndrome?
Menkes kinky hair syndrome, also called copper transport disease, is a rare inherited disorder that causes a deficiency in copper. The syndrome is caused by mutations in the ATP7A gene located on the X chromosome. It is passed from parent to child in an X-linked recessive manner. This means that girls must inherit two copies of the mutated gene in order to be affected. Because boys only have one X chromosome, they can be affected if the mutation is present on the one X chromosome.
The mutation leads to uneven distribution of copper in the body. It may build up in tissues of the intestines and kidneys, for example, but may be deficient in areas such as the brain. Symptoms of the syndrome typically develop in infancy and many children die at a young age. Signs and symptoms include sparse, kinky hair, failure to grow at an expected rate and developmental delay, nervous system deterioration, weak muscle tone and seizures. The incidence of this syndrome is about 1 in 100,000 infants.